Novartis India Limited (NOVARTIND.BO)

INR 998.85

(-1.78%)

Market Cap (In INR)

24.66 Billion

Revenue (In INR)

3.35 Billion

Net Income (In INR)

851.9 Million

Avg. Volume

12.69 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
699.0-1248.0
PE
-
EPS
-
Beta Value
0.307
ISIN
INE234A01025
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Vasant Narasimhan M.D.
Employee Count
-
Website
https://www.novartis.in
Ipo Date
2000-01-03
Details
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.